Performance of BXP Beximco Pharmaceuticals.. | 6% in 12m
Compare BXP with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Beximco Pharmaceuticals.. with its related Sector/Index XBI
Performance Duell BXP vs XBI
| TimeFrame | BXP | XBI |
|---|---|---|
| 1 Day | 2.74% | 0.67% |
| 1 Week | 2.74% | 5.92% |
| 1 Month | 2.74% | 0.44% |
| 3 Months | 0.00% | 0.91% |
| 6 Months | 6.03% | 29.64% |
| 12 Months | 6.03% | 6.11% |
| YTD | -9.64% | 0.39% |
| Rel. Perf. 1m | 0.05 | |
| Rel. Perf. 3m | -1.60 | |
| Rel. Perf. 6m | -1.79 | |
| Rel. Perf. 12m | -1.26 |
Is Beximco Pharmaceuticals.. a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Beximco Pharmaceuticals.. (LSE:BXP) is currently (May 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 83.72 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BXP as of May 2024 is 34.82. This means that BXP is currently overvalued and has a potential downside of -7.15% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BXP as of May 2024 is 34.82. This means that BXP is currently overvalued and has a potential downside of -7.15% (Sold with Premium).
Is BXP a buy, sell or hold?
Beximco Pharmaceuticals.. has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of 6.03%.
In compare to SPDR S&P Biotech, BXP made -0.08% less over the last 12 months. Due to the inline performance, it is recommend to hold BXP.
In compare to SPDR S&P Biotech, BXP made -0.08% less over the last 12 months. Due to the inline performance, it is recommend to hold BXP.
Values above 0%: BXP is performing better - Values below 0%: BXP is underperforming
Compare BXP with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.46% | 3.10% | -13.38% | -20.97% |
| US NASDAQ 100 | QQQ | 1.01% | 2.79% | -13.67% | -31.23% |
| US Dow Jones Industrial 30 | DIA | 1.53% | 2.79% | -8.94% | -11.56% |
| German DAX 40 | DBXD | 2.48% | 2.75% | -13.78% | -7.40% |
| UK FTSE 100 | ISFU | 1.93% | -0.86% | -7.92% | -2.72% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.54% | -0.66% | 4.15% | 17.20% |
| Hongkong Hang Seng | HSI | -1.94% | -6.09% | 6.99% | 20.14% |
| Japan Nikkei 225 | EXX7 | 0.12% | 4.87% | -9.72% | -13.66% |
| India NIFTY 50 | INDA | 3.04% | 2.07% | -12.48% | -20.71% |
| Brasil Bovespa | EWZ | 0.91% | 1.11% | 1.48% | -13.25% |
BXP Beximco Pharmaceuticals.. vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.06% | 4.22% | -15.25% | -34.65% |
| Consumer Discretionary | XLY | 2.85% | 2.20% | -6.50% | -17.08% |
| Consumer Staples | XLP | 2.62% | 0.60% | -5.88% | 4.79% |
| Energy | XLE | 5.95% | 7.61% | -4.77% | -14.28% |
| Financial | XLF | 1.98% | 3.94% | -16.97% | -23.27% |
| Health Care | XLV | 2.05% | 4.01% | -5.11% | -1.55% |
| Industrial | XLI | 2.31% | 4.06% | -17.40% | -20.68% |
| Materials | XLB | 2.96% | 5.65% | -10.07% | -9.36% |
| Real Estate | XLRE | 2.31% | 6.26% | -2.77% | 3.60% |
| Technology | XLK | 0.63% | 3.48% | -12.96% | -30.57% |
| Utilities | XLU | 0.25% | -2.78% | -7.39% | 2.99% |
| Aerospace & Defense | XAR | -0.46% | - | -12.35% | -20.05% |
| Biotech | XBI | -3.18% | 2.30% | -23.61% | -0.08% |
| Homebuilder | XHB | 0.46% | 4.33% | -34.27% | -46.23% |
| Retail | XRT | 1.26% | 3.26% | -15.45% | -17.16% |
Does Beximco Pharmaceuticals.. outperform its market, is BXP a Sector Leader?
No, over the last 12 months Beximco Pharmaceuticals.. (BXP) made 6.03%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.11%.
Over the last 3 months BXP made 0.00%, while XBI made 0.91%.
No, over the last 12 months Beximco Pharmaceuticals.. (BXP) made 6.03%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.11%.
Over the last 3 months BXP made 0.00%, while XBI made 0.91%.
| Period | BXP | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 2.74% | 0.44% | -0.36% |
| 3 Months | 0.00% | 0.91% | 4.90% |
| 12 Months | 6.03% | 6.11% | 27.00% |